GAMB vs GENI vs SRAD vs DKNG

For growth investors, Genius Sports Limited (GENI) is the stronger pick with 31.

0% revenue growth year-over-year, versus 12. 0% for Sportradar Group AG (SRAD). Gambling. com Group Limited (GAMB) offers the better valuation at 5. 3x trailing P/E (8. 8x forward), making it the more compelling value choice. Analysts rate Gambling. com Group Limited (GAMB) a "Buy" — based on 8 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Gambling.

com Group Limited (GAMB) is the cheapest at 5. 3x versus Sportradar Group AG at 38. 7x. On forward P/E, Gambling. com Group Limited is actually cheaper at 8. 8x.

Over the past 5 years, Gambling.

com Group Limited (GAMB) delivered a total return of -44. 8%, compared to -74. 6% for Genius Sports Limited (GENI). Over 10 years, the gap is even starker: DKNG returned +160. 4% versus GENI's -56. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Sportradar Group AG (SRAD) is the lower-risk stock at 0.

63β versus Genius Sports Limited's 1. 39β — meaning GENI is approximately 120% more volatile than SRAD relative to the S&P 500. On balance sheet safety, Genius Sports Limited (GENI) carries a lower debt/equity ratio of 4% versus 3% for DraftKings Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Genius Sports Limited (GENI) is pulling ahead at 31.

0% versus 12. 0% for Sportradar Group AG (SRAD). On earnings-per-share growth, the picture is similar: Sportradar Group AG grew EPS 200. 0% year-over-year, compared to -63. 0% for Genius Sports Limited. Over a 3-year CAGR, GAMB leads at 44. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Gambling.

com Group Limited (GAMB) is the more profitable company, earning 24. 1% net margin versus -16. 7% for Genius Sports Limited — meaning it keeps 24. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: GAMB leads at 28. 1% versus -15. 6% for GENI. At the gross margin level — before operating expenses — GAMB leads at 94. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Gambling.

com Group Limited (GAMB) trades at 8. 8x forward P/E versus 161. 2x for Genius Sports Limited — 152. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for GENI: 134. 4% to $11. 17.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Sportradar Group AG (SRAD) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

63)). Both have compounded well over 10 years (SRAD: -47. 9%, GENI: -56. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (GAMB (Consumer Cyclical) and GENI (Communication Services) and SRAD (Technology) and DKNG (Consumer Cyclical)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: GAMB is a small-cap high-growth stock; GENI is a small-cap high-growth stock; SRAD is a small-cap quality compounder stock; DKNG is a mid-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.